Pioneering bacterial therapy for the skin. | Pioneering bacterial therapy for the skin
36 Patients
2 Week Phase 2
240 Patients
12 Week Phase 3
BLA Filing
36 Subjects (R/L)
4 Week Cosmetic
240 Patients (R/L)
4 Week Phase 3
30 Subjects (R/L)
4 Week Cosmetic
180 Patients
4 Week Phase 3
82 Subjects
12 Week Cosmetic
240 Patients
12 Week Phase 3
AOBiome Therapeutic Pipeline
Skin Conditions
Acne
(Science37)
Keratosis
Pilaris
(SkinCare Physicians)
Eczema
Rosacea
Welcome to AOBiome.
AOBiome is dedicated to advancing the science of AOB on human health. The human microbiome when subjected to modern hygienic routines selectively depletes potentially important Ammonia Oxidizing Bacteria (AOB).

Topical applications of patented and stabilized Ammonia Oxidizing Bacteria can restore the skin's microbiome and potentially impact a wide variety of human health conditions.

We conduct primary research, collaborate with others on research and develop applications to positively impact skin conditions,reduce inflammation and risk of infection.